Artivion | CRY - SCHULD





SCHULD Veränderung Datum
Abbott USD 34.05B 20.19B 2026-03
Accuray USD 170.24M 4.52M 2024-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 71.78M 1.6M 2026-03
Baxter International USD 9.78B 68M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Edwards Lifesciences USD 600M 105.4M 2026-03
Inogen USD 0 0 2022-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
J&J USD 54.99B 7.05B 2026-03
Mesa Laboratories USD 204.98M 7.27M 2024-09
Orthofix International USD 137.23M 338K 2024-09
Pfizer USD 63.73B 231M 2026-03
ResMed USD 847.72M 1.37M 2025-12
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Teleflex USD 2.73B 43.5M 2025-12
Terumo JPY 159.87B 14.97B 2025-09
Trinity Biotech USD 137.98M 37.22M 2025-12